10-23-2015, 08:21 PM
I bought ABBV at around 48 two days ago right before market close. I was frantically googling revenues for Viekera and I'm happy with ABBV's 27 other products, the somewhat diversified revenues (Humira going off patent is a little scary), & the purchase of Pharmacyclics shows that they're trying.
Plus, the people who unfortunately died taking the Viekera were pretty sick to begin with.
Plus, the people who unfortunately died taking the Viekera were pretty sick to begin with.